The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Open accessAbstract
Fungal bloodstream infections are associated with significant patient mortality and health care costs. Nevertheless, the relationship between a delay of the initial empiric antifungal treatment until blood culture results are known and the clinical outcome is not well established. A retrospective cohort analysis with automated patient medical records and the pharmacy database at Barnes-Jewish Hospital was conducted. One hundred fifty-seven patients with a Candida bloodstream infection were identified over a 4-year period (January 2001 through December 2004). Fifty (31.8%) patients died during hospitalization. One hundred thirty-four patients had empiric antifungal treatment begun after the results of fungal cultures were known. From the time that the first blood sample for culture that was positive was drawn, 9 (5.7%) patients received antifungal treatment within 12 h, 10 (6.4%) patients received antifungal treatment between 12 and 24 h, 86 (54.8%) patients received antifungal treatment between 24 and 48 h, and 52 (33.1%) patients received antifungal treatment after 48 h. Multiple logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (one-point increments) (adjusted odds ratio [AOR], 1.24; 95% confidence interval [CI], 1.18 to 1.31; P < 0.001), prior antibiotic treatment (AOR, 4.05; 95% CI, 2.14 to 7.65; P = 0.028), and administration of antifungal treatment 12 h after having the first positive blood sample for culture (AOR, 2.09; 95% CI, 1.53 to 2.84; P = 0.018) as independent determinants of hospital mortality. Administration of empiric antifungal treatment 12 h after a positive blood sample for culture is drawn is common among patients with Candida bloodstream infections and is associated with greater hospital mortality. Delayed treatment of Candida bloodstream infections could be minimized by the development of more rapid diagnostic techniques for the identification of Candida bloodstream infections. Alternatively, increased use of empiric antifungal treatment in selected patients at high risk for fungal bloodstream infection could also reduce delays in treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Finally, in a study of 10,811 patients treated in four Utah hospitals, each hour delay in time from ED arrival to administration of antimicrobials was associated with 1.16 increased odds of in-hospital and 1.10 increased odds of 1-year mortality (1.13 in patients with hypotension vs 1.09 in patients without hypotension) (111).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredIn the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [173]
In the citing paper
“As mentioned previously, diagnosis of invasive candidiasis and candidemia remains a great challenge, since symptoms and signs are usually non-specific, microbiological cultures are difficult to analyze, and histological specimens require invasive procedures [29,30,46].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [30]
In the citing paper
“Another single-center retrospective cohort of 157 consecutive patients with a Candida BSI showed a trend toward improved survival when appropriate antifungal therapy was administered within 12 hours of blood culture collection (mortality 11.1% vs 33.1%; P 5 .169).45”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“In multivariate analysis the odds of death was 2-fold higher if adequate therapy was delayed more than 12 hours (P 5 .018).”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“Invasive candidiasis occurs frequently in hospitalized patients, and is associated with high mortality rates due to delays in recognition and initiation of appropriate antifungals.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“There is extensive clinical evidence that delayed initiation of appropriate antifungal treatment is associated with increased mortality in patients with invasive candidiasis [70,71,72].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“Mortality rates are estimated to be as high as 45% [16], probably due to inefficient diagnostic methods and inappropriate initial antifungal therapies [17].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [17]
In the citing paper
“The Clinical and Laboratory Standards Institute (CLSI) Subcommittee for Antifungal Testing has developed standardized broth microdilution (BMD) (169) and disk diffusion (170) methods for in vitro susceptibility testing of Candida spp.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Reller, L. B. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,225
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
The Risk of Determining Risk with Multivariable Models
Concato, J., Feinstein, A. R., & Holford, T. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00009 · Cited by 1,119
Cited by
Sorted by citations
Items 801–900 of 1,000
Prise en charge des infections systémiques à Candida spp.
Taieb, F., Mechai, F., Lefort, A., Lanternier, F., Bougnoux, M., & Lortholary, O. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.08.019 · Cited by 10
Masterton, R. G., Casamayor, M., Musingarimi, P., van Engen, A., Zinck, R., Odufowora-Sita, O., & Odeyemi, I. A. O. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.839948 · Cited by 10
Approaches to the early treatment of invasive fungal infection
Ito, J. I., Kriengkauykiat, J., Dadwal, S., Arfons, L. M., & Lazarus, H. M. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.496504 · Cited by 10
Pang, Y., Ip, M., & You, J. H. S. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2796-4 · Cited by 11
Taghipour, S., Rezaei‐Matehkolaei, A., & Mahmoudabadi, A. Z. (2018) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.78851 · Cited by 10
Bordallo-Cardona, M. Á., Sánchez‐Carrillo, C., Bouza, E., Muñóz, P., Escribano, P., & Guinea, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02004-18 · Cited by 10
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000298158.12101.41 · Cited by 9
Soriano, À., Honoré, P. M., Cornely, O. A., Chayakulkeeree, M., Bassetti, M., Haihui, H., Dupont, H., Kim, Y. K., Kollef, M. H., Kullberg, B. J., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae363 · Cited by 9
Self-citationPHGDH/SYK: a hub integrating anti-fungal immunity and serine metabolism
Chen, A., Zhang, X., Hu, D., Sun, X., Gu, Y., Zhou, Y., Su, C., Liu, S., Zhang, C., Wu, Q., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01374-7 · Cited by 9
Suárez-Urquiza, P., Pemán, J., Gordón, M., Favier, P., Muñoz-Brell, P., López-Hontangas, J. L., & Gaitán, A. C. R. (2024) · Journal of Fungi · doi:10.3390/jof10100674 · Cited by 10
Healthcare‐associated candidemia—A distinct entity?
Gulia, J., Aryal, S., Saadlla, H., & Shorr, A. F. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.652 · Cited by 9
Haltmeier, T., Inaba, K., Effron, Z., Dollbaum, R., Shulman, I. A., Benjamin, E., Lam, L., & Δημητριάδης, Δ. (2015) · The American Surgeon · doi:10.1177/000313481508101031 · Cited by 9
Update: invasive Pilzinfektionen: Diagnose und Therapie in der operativen Intensivmedizin
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · Cited by 9
Candida albicans resistance to hypochlorous acid
Douglas, L. M., Min, K., & Konopka, J. B. (2023) · mBio · doi:10.1128/mbio.02671-23 · Cited by 9
Utility of Antifungal Susceptibility Testing and Clinical Correlations
Diekema, D. J., & Pfaller, M. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-59745-134-5_8 · Cited by 9
[Nosocomial candidemia: new challenges of an emergent problem].
Gómez, J. G., Vázquez, E. G., Hernández, A., Espinosa, C., & Pardo, J. R. (2010) · PubMed · Cited by 13
Ueda, S., Miyamoto, S., Kaida, K., Chizuka, A., Kojima, R., Takano, J., Ogasawara, T., Miyamoto, K., Miyakoshi, S., & Kanda, Y. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.01.009 · Cited by 9
Hare, D., Coates, C., Kelly, M., Cottrell, E., Connolly, E., Muldoon, E. G., Connell, B. O., Rogers, T. R., & Talento, A. F. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100047 · Cited by 9
Update: invasive Pilzinfektionen
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · doi:10.1007/s00101-009-1655-4 · Cited by 11
When and How to Cover for Fungal Infections in Patients with Severe Sepsis and Septic Shock
Allou, N., Allyn, J., & Montravers, P. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0204-x · Cited by 9
Taniguchi, T., Ogawa, Y., Kasai, D., Watanabe, D., Yoshikawa, K., Bando, H., Yajima, K., Tominari, S., Shiiki, S., Nishida, Y., et al. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3811 · Cited by 9
Pagès, A., Iriart, X., Molinier, L., Georges, B., Berry, A., Massip, P., & Juillard‐Condat, B. (2017) · Value in Health · doi:10.1016/j.jval.2017.06.009 · Cited by 9
Muthuraja, P., Sengodu, P., Venkatesan, S., Perumal, S., Antony, S. A., & Paramsivam, M. (2017) · ChemistrySelect · doi:10.1002/slct.201700918 · Cited by 9
A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2017
Chastain, D. B., Cluck, D. B., Stover, K. R., Lusardi, K. T., Marx, A. H., Green, S. B., Faulkner-Fennell, C., Turner, M., Chahine, E. B., Bookstaver, P. B., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz133 · Cited by 9
Leroy, O., Mira, J. P., Montravers, P., Gangneux, J., Gouin, F., Sollet, J.-P., Carlet, J. M., Reynes, J., Rosenheim, M., Regnier, B., et al. (2008) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2008.10.004 · Cited by 9
Does One Voriconazole Breakpoint Suit All Candida Species?
Arendrup, M. C., & Denning, D. W. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00412-07 · Cited by 9
Cortegiani, A., Russotto, V., Raineri, S. M., Gregoretti, C., & Giarratano, A. (2017) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.5152/tjar.2016.0010 · Cited by 9
Kokkoris, S., Angelopoulos, E. T., Gkoufa, A., Christodouli, F., Ntaidou, T. K., Theodorou, E., Dimopoulou, G., Vasileiadis, I., Kremmydas, P., & Routsi, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123557 · Cited by 8
Early-Onset Candidemia in Adult Intensive Care Units
Mouratidou, C., Tsakiri, K., Dourliou, V., Marneri, A. G., Stougianni, M., & Pavlidis, E. T. (2025) · Diagnostics · doi:10.3390/diagnostics15111402 · Cited by 9
Reuber, E. E., Hickey, E., Pradhan, A., Sprute, R., Lingscheid, T., Tober‐Lau, P., Leaves, I., Stappers, M. H. T., Kurth, F., Bruno, M., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2505340122 · Cited by 8
Borman, A. M., & Johnson, E. M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0149-7 · Cited by 8
New Antifungal and Antiviral Dosing
Wade, K. C., & Monk, H. M. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2014.10.010 · Cited by 8
Prognostic factors of candidemia among nonneutropenic adults with total parenteral nutrition
Tsai, C., Lay, C.-J., Wang, C.-L., Lin, M.-L., & Yang, S.-P. (2011) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2011.04.002 · Cited by 8
Time to Initiation of Antifungal Therapy for Neonatal Candidiasis
Lê, J., Tran, T. T. L., Bui, I., Wang, M. K., Vo, A., & Adler‐Shohet, F. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02088-12 · Cited by 8
Wang, Y., Xie, J., Xing, Y., Chen, L., Li, Y., Meng, T., Dong, W., Wang, X., & Dong, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00620-17 · Cited by 8
Performance of Microflex LT Biotyper and VITEK MS for Routine Identification of Yeasts
Byun, J., Yu, A.-R., Kim, M. S., & Lee, K. (2018) · Annals of Laboratory Medicine · doi:10.3343/alm.2018.38.5.487 · Cited by 8
Antifungal Stewardship in Low- and Middle-Income Countries
Riera, F. O., Caeiro, J. P., & Sotomayor, C. E. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-00197-2 · Cited by 8
Candida spp. DNA Extraction in the Age of Molecular Diagnosis
Codreanu, S. I., & Ciurea, C. N. (2023) · Microorganisms · doi:10.3390/microorganisms11040818 · Cited by 9
Development of anidulafungin for disk diffusion susceptibility testing against Candida spp.
Jones, R. N., Kirby, J. T., Messer, S. A., & Sheehan, D. J. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.018 · Cited by 8
Lee, S.-C., Lee, C., Shih, H.-J., Huang, S.-H., Chiou, M., & See, L. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.09.006 · Cited by 8
Echinocandin Use in Hospitalized Patients: A Multi-institutional Study
Garey, K. W., Aitken, S. L., Dima-Ala, A., Beyda, N. D., Kuper, K. M., Xie, Y., & Koo, H. L. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000412 · Cited by 9
Strategies to manage antifungal drug resistance
Tseng, H.-K., & Perfect, J. R. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.517195 · Cited by 8
Soshee, A., Boosi, K. N., Bugatha, H., Padmanabhan, B., & Sadhale, P. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016868 · Cited by 8
Management of candidemia in patients withClostridium difficileinfection
Falcone, M., Venditti, M., Sanguinetti, M., & Posteraro, B. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1197118 · Cited by 8
The laboratory and clinical mycology
Pfaller, M. A., & McGinnis, M. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00004-9 · Cited by 8
Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
Honarvar, B., Lankarani, K. B., Taghavi, M., Vahedi, G., & Mortaz, E. (2019) · Current Medical Mycology · doi:10.18502/cmm.4.4.385 · Cited by 8
A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2018
Chahine, E. B., Durham, S. H., Mediwala, K. N., Chastain, D. B., Gauthier, T. P., Hill, B. K., Jones, B. M., Kisgen, J. J., Marx, A. H., Stover, K. R., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz450 · Cited by 8
Aljeboori, Z., Gorelik, A., Jenkins, E., McFarlane, T., & Darvall, J. N. (2018) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00971-7 · Cited by 8
Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
Suh, J. W., Kim, S. B., Yoon, Y. K., Sohn, J. W., Kim, M. J., & Kim, J. H. (2020) · Mycopathologia · doi:10.1007/s11046-020-00471-8 · Cited by 8
Recomendaciones para el diagnóstico de la candidemia en América Latina
Colombo, A. L., Cortés, J. A., Zurita, J., Guzmán-Blanco, M., Matute, T. A., Telles, F. D. Q., Santolaya, M. E., Tiraboschi, I. N., Echevarria, J. I., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.009 · Cited by 8
Denny, S., Abdolrasouli, A., Elamin, T., Gonzalo, X., Charani, E., Patel, A. M., Donaldson, H., Hughes, S., Armstrong-James, D. P. H., Moore, L. S. P., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.02.020 · Cited by 8
Pongrácz, J., Szabó, T. G., Juhász, E., Iván, M., & Kristóf, K. (2025) · Mycopathologia · doi:10.1007/s11046-025-00965-3 · Cited by 9
Lodise, T. P., Garey, K. W., Aram, J. A., Nathanson, B. H., & Redell, M. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf472 · Cited by 7
Kim, J. H., Suh, J. W., Kim, J. Y., Kim, S. B., Yoon, Y. K., Sohn, J. W., & Kim, M. J. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101102 · Cited by 7
Cross-sectional investigation of mycological diagnosis challenges in Saudi Arabia
Khateb, A. M., & Alkhaibari, S. A. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1203892 · Cited by 7
Empirical Therapy for Invasive Candidiasis in Critically Ill Patients
Bartalucci, C., Giacobbe, D. R., Vena, A., & Bassetti, M. (2024) · Current Fungal Infection Reports · doi:10.1007/s12281-024-00489-1 · Cited by 8
Controversies in Candida management
Zakhem, A. E., Saad, H. A., Tayyar, R., & Kanj, S. S. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.008 · Cited by 7
Grant, M. L., Parajuli, S., Deleon-Gonsalves, R., Potula, R., & Truant, A. L. (2016) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2016/4094932 · Cited by 7
Mechanisms of Drug Resistance in Candida albicans
Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 7
Introduction to Medical Mycology
Chakrabarti, A., & Sethuraman, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_1 · Cited by 7
Dib, R. W., Hachem, R. Y., Chaftari, A., & RAAD, I. I. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.028 · Cited by 7
Clinical Syndromes: Candida and Candidosis
Ruhnke, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-92300-0_4 · Cited by 7
Zand, F., Mohsen, Davarpanah, M. A., Masjedi, M., Nikandish, R., Amanati, A., Afarid, M., Nafarieh, L., & Nami, M. (2016) · Bioscience Biotechnology Research Communications · doi:10.21786/bbrc/9.3/6 · Cited by 7
Dahal, N., Osterberg, J. A., Braun, B., Caldwell, T. P., Divan, R., Harcum, S. W., & Wang, P. (2022) · IEEE Journal of Electromagnetics RF and Microwaves in Medicine and Biology · doi:10.1109/jerm.2022.3201698 · Cited by 7
Townell, N., McDougall, D. A. J., & Playford, E. G. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.880185 · Cited by 7
A Case of Pediatric Acute Lymphoblastic Leukemia with Invasive Candidiasis: Short Review
Verma, S., Dubashi, B., Parameswaran, N., Basu, D., Dutta, T. K., & Dhanraj, K. M. (2013) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-013-0274-z · Cited by 7
Pharmacotherapy of Candida Infections with Echinocandins
Espinel-Ingroff, A. V., Canton, E., Martín‐Mazuelos, E., & Pemán, J. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2311 · Cited by 7
Riwes, M. M., Leather, H. L., Neal, D. W., Bennett, C., Sugrue, M. W., Cline, C. L., Stokes, J. C., Hiemenz, J., Hsu, J., & Wingard, J. R. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.92 · Cited by 7
Stallmach, A., Hagel, S., Bruns, T., Pletz, M. W., & Eckmann, C. (2013) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0033-1335043 · Cited by 7
Arens, C., Kramm, T., Decker, S., Spannenberger, J., Brenner, T., Richter, D., Weigand, M. A., Uhle, F., & Lichtenstern, C. (2018) · Shock · doi:10.1097/shk.0000000000001251 · Cited by 7
Expect the unexpected: fungemia caused by uncommon Candida species in a Turkish University Hospital
Alp, Ş., Gülmez, D., Kardaş, R. C., Karahan, G., Taş, Z., Gürsoy, G., Ayaz, Ç. M., Arıkan-Akdağlı, S., & Akova, M. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04147-5 · Cited by 7
[Recommendations of antifungal treatment in patients with low grade immunosuppression].
Barberán, J., Mensa, J., Fariñas, C., Llinares, P., Serrano, R., Menéndez, R., Agustí, C., Gobernado, M., Azanza, J. R., & Rodríguez, J. A. G. (2008) · PubMed · Cited by 14
Clinical significance of time to positivity for yeast in candidemia
Chen, L.-Y., Yang, S.-P., Chen, T.-L., Liao, S.-Y., Chen, Y.-Y., Chan, Y., Chen, L., & Wang, F. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.11.002 · Cited by 7
Use of multiplex PCR in diagnosis of bloodstream infections in kidney patients
Fernández-Romero, N., Quiles, I., Jiménez, C., López‐Oliva, M. O., Rivas, B., Mingorance, J., & Romero‐Gómez, M. P. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.001 · Cited by 7
Candida Colonization Index in the Management of Critically III Patients
Eggimann, P., & Pittet, D. (2006) · Yearbook of intensive care and emergency medicine · doi:10.1007/3-540-33396-7_56 · Cited by 7
Critical overview of clinical guidelines relating to invasive fungal infections
Sá, M. B., & Zaragoza, R. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70018-9 · Cited by 7
Nosocomial candidemia in adults: Risk and prognostic factors
Gürcüoğlu, E., Akalın, H., Ener, B., Ocakoğlu, G., Sınırtaş, M., Akçağlar, S., Yılmaz, E., Evci, C., & Oral, H. B. (2010) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2010.07.006 · Cited by 7
Pharmacological advances in the treatment of invasive candidiasis
Deck, D. H., & Guglielmo, B. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.137 · Cited by 7
Refractory versus resistant invasive aspergillosis
Arendrup, M. C., & Cordonnier, C. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf003 · Cited by 6
Almirante, B., & Cuenca‐Estrella, M. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.03.002 · Cited by 5
Impact of the antimicrobial stewardship program on hospital-acquired candidemia
Hadano, Y., Suyama, A., Miura, A., Fujii, S., Suzuki, Y., Tomoda, Y., & Awaya, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-19374-3 · Cited by 8
Laroche, L., Mercier, V., & Sasso, M. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115863 · Cited by 6
Fang, X., Su, C., Luo, Y., Pan, K., Lin, J., You-liang, S., Huang, Y., Hu, X., & Shen, Z. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156803 · Cited by 8
Boğa, C., Bolaman, Z., Çağırgan, S., Karadoǧan, Ì., Özcan, M. A., Özkalemkaş, F., Saba, R., Sönmez, M., Şenol, E., Akan, H., et al. (2015) · Turkish Journal of Hematology · doi:10.4274/tjh.2014.0277 · Cited by 6
Nagy, E., Ábrók, M., Bartha, N., Bereczki, L., Juhász, E., Kardos, G., Kristóf, K., Miszti, C., & Urbán, E. Z. (2014) · Orvosi Hetilap · doi:10.1556/oh.2014.29985 · Cited by 6
Kim, W.-H., Kim, S. M., Yu, H., Jang, M. J., Baek, S. D., & Kim, S. B. (2017) · Hemodialysis International · doi:10.1111/hdi.12548 · Cited by 6
Khanina, A., Cairns, K. A., Kong, D. C. M., Thursky, K., Slavin, M. A., & Roberts, J. A. (2021) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1721 · Cited by 6
Candida Infections in Solid Organ Transplantation
Barros, N., & Mansour, M. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_43 · Cited by 6
Mapping the Substrate-Binding Sites in the Phosphatidylserine Synthase in Candida albicans
Zhou, Y., Cassilly, C. D., & Reynolds, T. B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765266 · Cited by 6
Dudakova, A., Blei, C., Groß, U., & Schulze, M. H. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.03.054 · Cited by 6
Cabanilla, M. G., Briski, M. J., Bruss, Z. S., Saa, L., Vasquez, P. C., Rodriguez, C. N., Mitchell, J. A., Bernauer, M. L., Argyropoulos, C., Crandall, C. S., et al. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2255680 · Cited by 6
Yan, J.-Y., Lin, T.-H., Jong, Y.-T., Hsueh, J.-W., Wu, S.-H., Lo, H., Chen, Y., & Pan, C.-H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1278600 · Cited by 6
Gompelmann, D., Heußel, C. P., Schuhmann, M. U., & Herth, F. J. F. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01983.x · Cited by 6
Candidaemia in a tertiary hospital in Nigeria
Oladele, R. O., Bakare, R. A., Petrou, M. A., Oduyebo, O. O., & Richardson, M. D. (2014) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v3i1.89 · Cited by 8
In Vitro Susceptibility of Candida Isolates from Organ Transplant Recipients to Newer Antifungals
Geusau, A., Antoniewicz, L., Poitschek, C., Presterl, E., & Willinger, B. (2014) · Mycopathologia · doi:10.1007/s11046-014-9738-4 · Cited by 6
Elhoufi, A. M. (2014) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v3.i4.102 · Cited by 6
Ochiuzzi, M. E., Arechavala, A. I., Guelfand, L. I., Maldonado, I., & Soloaga, R. N. (2014) · Revista Argentina de Microbiología · doi:10.1016/s0325-7541(14)70058-6 · Cited by 6
Soroksky, A., Nagornov, S., Klinowski, E., Leonov, Y., Ilgiyaev, E., Yossepowitch, O., & Goltsman, G. (2014) · PubMed · Cited by 6
The Role of Conventional Diagnostic Tools
Verweij, P. E., van der Lee, H. A. L., & Rijs, A. J. M. M. (2007) · CRC Press eBooks · doi:10.3109/9781420017182.002 · Cited by 6
Armaganidis, A., Nanas, S., Antoniadou, E., Mandragos, K. E., Liakou, K., Koutsoukou, A., Baltopoulos, G. J., Nakos, G., Kounougeri, A., Ganas, K., et al. (2017) · Mycoses · doi:10.1111/myc.12616 · Cited by 6
Metadata
- Authors
- Morrell, M., Fraser, V. J., & Kollef, M. H.
- Affiliations
- Washington University in St. Louis (US)
- Pulmonary and Critical Care Division
- Corresponding author
- Kollef, Marin H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-09
- Volume
- 49
- Issue
- 9
- Pages
- 3640-3645
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1195428
- OpenAlex
- W2137575148
- Cited by
- 1,286
- References
- 47
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 41 · 2023: 33 · 2022: 53 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 65 · 2017: 67 · 2016: 71 · 2015: 77 · 2014: 97 · 2013: 75 · 2012: 78
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- candidemia, fungemia, empirical antifungal therapy, treatment delay, blood culture, in-hospital mortality, APACHE II score, prior antibiotic use, rapid diagnostic tests
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candidiasis, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Cohort Studies, Logistic Models, Fungemia, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
